FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082464 [Registered on: 17/03/2025] Trial Registered Prospectively
Last Modified On: 06/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Ayuevedic management of thin endometrium  
Scientific Title of Study   Efficacy of Ardhamatrika Yogabasti, Shatapushpadi Taila Uttarbasti and Tila Kwatha orally in the management of Vandhyatva(female infertility) w.s.r. to thin endometrium - A single arm open labelled clinical trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rinkalben Kantibhai Bumtariya 
Designation  M.S. scholar 
Affiliation  Institute of Teaching and Reseach in Ayurveda,Jamnagar 
Address  Department of Prasutitantra evum Streeroga, fifth floor,Institute building, ITRA Jamnagar, Gujarat

Jamnagar
GUJARAT
361008
India 
Phone  7486855126  
Fax    
Email  rinkalkantibhai@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shilpa Donga 
Designation  Professor ,HOD 
Affiliation  Institute of Teaching and Reseach in Ayurveda,Jamnagar 
Address  Department of Prasutitantra evum Streeroga, fifth floor,Institute building, ITRA Jamnagar, Gujarat

Jamnagar
GUJARAT
361008
India 
Phone  9825646796  
Fax    
Email  drshilpadonga@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shilpa Donga 
Designation  Professor ,HOD 
Affiliation  Institute of Teaching and Reseach in Ayurveda,Jamnagar 
Address  Department of Prasutitantra evum Streeroga, fifth floor,Institute building, ITRA Jamnagar, Gujarat


GUJARAT
361008
India 
Phone  9825646796  
Fax    
Email  drshilpadonga@yahoo.com  
 
Source of Monetary or Material Support  
Institute of Teaching & Research in Ayurveda,INI,Opp.B-Division Police Station, Gurudwara Road, Jamnagar,Gujarat-361008 
 
Primary Sponsor  
Name  Institute of Teaching and Research in Ayurveda 
Address  Institute of Teaching & Research in Ayurveda, INI, Opp.B-Division Police,Gurudwara Road,Jamnagar,Gujarat-361008 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rinkalben Kantibhai Bumtariya  Institute of Teaching and Research in Ayurveda  OPD NO:6, Streeroga OPD, Institute of Teaching and Research in Ayurveda,INI,Opp.B-police station, Gurudwara road,Jamnagar-361008
Jamnagar
GUJARAT 
7486855126

rinkalkantibhai@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee,Institute of Teaching and Research in Ayurveda,Jamnagar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N972||Female infertility of uterine origin. Ayurveda Condition: VANDHYA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Tila Kwatha, Reference: Ashtangahridaya Samhita, Chikitsa Sthana, Gulma Chikitsa Adhyaya, Sutra 120-121, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: Vangasena Samhita/ Bastikarmadhikara 90/ 191-196, Procedure details: Ardhamatrika Yogabasti Procedure Basti will be administered through rectal route before 10 days of expected menstrual date in dose and pattern as below: Matra Basti (M) with 60ml of Tila Taila Ardhamatrika Niruha Basti (N) 500ml )
(1) Medicine Name: ardhamatrika Basti, Reference: Vangasena Samhita/ Bastikarmadhikara 90/ 191-196, Route: Rectal, Dosage Form: Kwatha/Kashaya, Dose: 500(ml), Frequency: od, Duration: 3 Days
3Intervention ArmProcedure-uttara-bastiH, उत्तर-बस्तिः (Procedure Reference: Kashyap Samhita(Vrddhajivakiya tantra)by Vrddha Jivaka, revised by Vatsya with Sanskrit introduction by Pandit Hemaraja with Vidyotini hindi commentery and hindi translation of Sanskrit introduction by Ayurvedalankar Sri Satyapal Bhisagacharya ,Kalpa Sthan ,Shatpushpa-Shatavari Kalpa Adhyay 5/23-25, Procedure details: After deepan ,pachana ,kostha shodhana and yogabasti then 5 ml uttarabasti of shatapushpadi taila for 6 days will be administered in form of intra uterine uttarbasti(IUUB)once in a day.)
(1) Medicine Name: Shatapushpadi taila, Reference: Kashyap Samhita(Vrddhajivakiya tantra)by Vrddha Jivaka, revised by Vatsya with Sanskrit introduction by Pandit Hemaraja with Vidyotini hindi commentery and hindi translation of Sanskrit introduction by Ayurvedalankar Sri Satyapal Bhisagacharya ,Kalpa Sthan ,Shatpushpa-Shatavari Kalpa Adhyay 5/23-25, Route: Vaginal, Dosage Form: Taila, Dose: 5(ml), Frequency: od, Duration: 6 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Female patients having primary or secondary infertility with endometrial thickness less than equal to 7mm diagnosed by TVS with ovulatory cycle and anovulatory cycle, Female patients fit for Basti and Uttarabasti 
 
ExclusionCriteria 
Details  Female patients having infertility due to bilateral tubal blockage, hydro or pyosalpinx, Carcinoma of reproductive tract, Active inflammatory disease, e.g. Acute PID, positive case of HIV, VDRL, HBsAg and HCV, Abnormal uterine anatomy, endometrial tuberculosis, myoma, endometriosis, Patients with history of cardiac diseases, chronic liver disease, uncontrolled hypertension (Systolic BP above 160 & Diastolic above 100 mmHg), uncontrolled diabetes mellitus (above the range of 160 mg/dl - RBS), Female patients contraindicated for Basti and Uttarabasti. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
It is expected to increase endometrial thickness  12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To correct menstrual irregularities like dysmenorrhoea and scanty menses, To increase the blood flow of uterus by colour doppler study  10 weeks 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   30/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Vandhyatva (Infertility) has been recognized since the Vedic period. Acharya Sushruta has included Vandhya in
Yonivyapadas and Artavavaha Strotasa Viddha Lakshanas. He has described four essential factors for fertility. Ritu
(fertile period), Kshetra (well primed, disease-free endometrial bed), Ambu (sufficient unobstructed blood circulation)
and Beeja (quality spermatozoa from unvitiated, healthy male and quality ovum from disease free, healthy female)
are essential factor for conception. In which uterine factors endometrial abnormalities play a major role in the
causation of infertility. Endometrium forms by the part of Prasada Rasa and Rakta Dhatu and Sthanika Agni. Ruksha
Guna of Vata and Ushna - Tikshna Guna of Pitta are the two main etiological factors affecting endometrium.
Rationality For the Selection of The Topic:
Endometrium plays a major role in establishing a pregnancy and any alteration in this, could be a potential cause for
failure of implantation thus affecting fertility. Extended oestrogen treatment and adjuvant therapy, such as low dose
aspirin, vaginal Sildenafil, etc. are used in modern science for improving endometrium thickness. Still, there isn’t any
proven incidence of this treatment. Other treatments like In-Vitro Fertilization (IVF) - Embryo Transfer (ET), Gamete
Intra Fallopian Transfer (GIFT), etc. are also available. But all these treatments require a healthy endometrium.So this
topic is selected.
Aims and Objective:
To evaluate the efficacy of Ardhamatrika Yogabasti, Shatapushpadi Taila Uttarabasti and Tila Kwatha orally in the
management of Vandhatyva (female infertility) w.s.r. to thin endometrium.
Materials And Methods:
20 patients should fulfill the inclusion criteria for thin endometrium and will be selected in the clinical study.
Follow-up:
Patients will be advised to visit the hospital every 2 weeks during the treatment and for 1 month after the treatment as
a follow-up. Side Effects:
These drugs have no known unwanted effects. It is possible that it may also cause some problems that we are not
aware of. Adverse Drug Reaction if any observed will be reported to the Pharmacovigilance cell of I.T.R.A.,
Jamnagar.
Results: The efficacy of the therapy will be assessed on the basis of subjective and objective criteria.
Benefits: Project will help us to resolve the research question. Collected information from this research project will
be kept confidential, all outcomes will be noted in tabular form and appropriate statistical tests will be applied to
compare the effect.
 
Close